Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Macrophage and Tumor Cell Cross-Talk Is Fundamental for Lung Tumor Progression: We Need to Talk
Poonam Sarode, Martina Barbara Schaefer, Friedrich Grimminger, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 105

Showing 26-50 of 105 citing articles:

The role of macrophages in non-small cell lung cancer and advancements in 3D co-cultures
Katarína Balážová, Hans Clevers, Antonella F. M. Dost
eLife (2023) Vol. 12
Open Access | Times Cited: 14
Engineering TGF-β inhibitor-encapsulated macrophage-inspired multi-functional nanoparticles for combination cancer immunotherapy
Jae‐Hyun Kim, Minjeong Kim, Seok‐Beom Yong, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 14
Therapeutic targeting of the tumor microenvironments with cannabinoids and their analogs: Update on clinical trials
Sheik Aliya, Marzieh Ramezani Farani, Eunsu Kim, et al.
Environmental Research (2023) Vol. 231, pp. 115862-115862
Closed Access | Times Cited: 13
Metabolism in tumour-associated macrophages: aquid pro quowith the tumour microenvironment
Xiang Zheng, Siavash Mansouri, Annika Krager, et al.
European Respiratory Review (2020) Vol. 29, Iss. 157, pp. 200134-200134
Open Access | Times Cited: 35
M1 Macrophage exosomes MiR‐21a‐5p aggravates inflammatory bowel disease through decreasing E‐cadherin and subsequent ILC2 activation
Jiaxi Lu, Deliang Liu, Yuyong Tan, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 6, pp. 3041-3050
Open Access | Times Cited: 32
Multifaceted Roles of Chemokine C-X-C Motif Ligand 7 in Inflammatory Diseases and Cancer
Qianmiao Wu, Huaijun Tu, Jian Li
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 21
Pericentromeric satellite lncRNAs are induced in cancer-associated fibroblasts and regulate their functions in lung tumorigenesis
N. I. Enukashvily, N. V. Ponomartsev, Avanee Ketkar, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 11
Surface engineered nanodiamonds: mechanistic intervention in biomedical applications for diagnosis and treatment of cancer
Tanima Dey, Anushikha Ghosh, Arka Sanyal, et al.
Biomedical Materials (2024) Vol. 19, Iss. 3, pp. 032003-032003
Open Access | Times Cited: 4
Anti-lung cancer synergy of low-dose doxorubicin and PD-L1 blocker co-delivered via mild photothermia-responsive black phosphorus
Hua‐Zhen Xu, Fei-Xiang Chen, Ke Li, et al.
Drug Delivery and Translational Research (2024)
Closed Access | Times Cited: 4
Integrated analysis of M2 macrophage-related gene prognostic model and single-cell sequence to predict immunotherapy response in lung adenocarcinoma
Meifang Li, Zhiping Wang, Bin Huang, et al.
Frontiers in Genetics (2025) Vol. 16
Open Access
FABP5 is a key player in metabolic modulation and NF-κB dependent inflammation driving pleural mesothelioma
Eleonora Vecchio, Raffaella Gallo, Selena Mimmi, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
Macrophage Polarization in Lung Diseases: From Mechanisms to Therapeutic Strategies
Jia Wang, Haitao Niu, Junwei Kang, et al.
Immunological Investigations (2025), pp. 1-27
Closed Access
Tumor microenvironment: a prospective target of natural alkaloids for cancer treatment
Yanming Luo, Shuangshuang Yin, Jia Lu, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 26
Mesothelioma Malignancy and the Microenvironment: Molecular Mechanisms
Francesca Cersosimo, Marcella Barbarino, Silvia Lonardi, et al.
Cancers (2021) Vol. 13, Iss. 22, pp. 5664-5664
Open Access | Times Cited: 25
Metformin modulate immune fitness in hepatocellular carcinoma: Molecular and cellular approach
Eslam E. Abd El-Fattah, Amr Y. Zakaria
International Immunopharmacology (2022) Vol. 109, pp. 108889-108889
Closed Access | Times Cited: 18
Increased TIM-3 expression in tumor-associated macrophages predicts a poorer prognosis in non-small cell lung cancer: a retrospective cohort study
Chi Zhang, Xu Liyun, Yongbin Ma, et al.
Journal of Thoracic Disease (2023) Vol. 15, Iss. 3, pp. 1433-1444
Open Access | Times Cited: 10
Research trends in lung cancer and the tumor microenvironment: a bibliometric analysis of studies published from 2014 to 2023
Zhilan Huang, Tingyi Xie, Wei Xie, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Dihydroartemisinin inhibits Lewis Lung carcinoma progression by inducing macrophages M1 polarization via AKT/mTOR pathway
Xiaoqian Xiao, Yanping Li, Yi Wang, et al.
International Immunopharmacology (2021) Vol. 103, pp. 108427-108427
Closed Access | Times Cited: 23
The Reality of Lung Cancer Paradox: The Impact of Body Mass Index on Long-Term Survival of Resected Lung Cancer. A French Nationwide Analysis from the Epithor Database
Marco Alifano, Elisa Daffrè, Antonio Iannelli, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4574-4574
Open Access | Times Cited: 22
Engineering Macrophages via Nanotechnology and Genetic Manipulation for Cancer Therapy
Xiaoling Ding, Xinchen Sun, Huihui Cai, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 15
Immunotherapeutic targets in non‐small cell lung cancer
Habib Sadeghirad, Tayyeb Bahrami, Sepideh Mehrpour Layeghi, et al.
Immunology (2022) Vol. 168, Iss. 2, pp. 256-272
Open Access | Times Cited: 14
Integrating scRNA and bulk-RNA sequencing develops a cell senescence signature for analyzing tumor heterogeneity in clear cell renal cell carcinoma
Qiming Gong, Yan Jiang, Junfeng Xiong, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Immune Modulation in Lung Cancer: Current Concepts and Future Strategies
Lena Gaissmaier, Petros Christopoulos
Respiration (2020) Vol. 99, Iss. 11, pp. 903-929
Open Access | Times Cited: 23
Senescence-related genes define prognosis, immune contexture, and pharmacological response in gastric cancer
Xiaogang Shen, Meng Wang, Wenxi Chen, et al.
Aging (2023)
Open Access | Times Cited: 7
Reprograming of Tumor-Associated Macrophages in Breast Tumor-Bearing Mice under Chemotherapy by Targeting Heme Oxygenase-1
Seung Hyeon Kim, Su‐Jung Kim, Jeongmin Park, et al.
Antioxidants (2021) Vol. 10, Iss. 3, pp. 470-470
Open Access | Times Cited: 16

Scroll to top